Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs

Over-expression of EGFR, as in most cases of ovarian cancer, is associated with advanced-stage disease and poor prognosis. Activation of EGFR signaling pathway is involved in increased cell proliferation, angiogenesis, metastasis, and decreased apoptosis. Tyrosine kinase activity is essential for si...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cao, Cong, Lu, Shan, Sowa, Alex, Kivlin, Rebecca, Amaral, Ashley, Chu, Wenming, Yang, Hui, Di, Wen, Wan, Yinsheng
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2519958/
https://ncbi.nlm.nih.gov/pubmed/18400375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2008.02.062
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares